In AR‐positive PCa, hormonal treatment resistance can arise via clonal selection, intracrine mechanisms or adaptation to decreased androgen (eg mutation, AR phosphorylation and bypass of the AR pathway).4 This evidence concerns the gene AR and posterior cortical atrophy.